TORONTO--(BUSINESS WIRE)--On January 18, 2023, the shareholders' motion to certify the causes of action and proceeding against Auxly Cannabis Group, Inc. (“XLY”) will be heard. Morganti & Co. is financing the litigation and will be reimbursed if there is a court approved resolution. If you purchased Auxly’s securities after September 20, 2018, you are encouraged to register on our Firm’s informational page found here: https://morgantico.com/auxly-cannabis-group-inc/. The Firm also represents investors in litigation against Aphria Inc. (TSX: “APHA”) and Wayland Group Corp. (formerly known as "Maricann") (CSE: “WAYL”). Morganti & Co. also represented investors that purchased shares of FSD Pharma, Inc. that has since been resolved.

Source: CBC News September 14, 2022 05:59 UTC